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Purpose: To investigate the biochemical mechanism of amniotic membrane (AM) suspension on corneal wound healing,
particularly on epithelial proliferation and migration.
Methods: Human corneal epithelial cells (HCECs) were cultured in media with different concentrations of AM suspension
(5% and 30%), Dulbecco's Modified Eagle Medium: Nutrient Mixture F-12 (negative control), and serum containing
Dulbecco's Modified Eagle Medium: Nutrient Mixture F-12 (positive control). In an effort to evaluate the migratory
potential of AM, migration assays were conducted via the manual scraping of HCECs and immunocytochemical staining
of cell adhesion molecules (E-cadherin). The relative expression of matrix metallopeptidase 9 (MMP9) and adhesion
molecules (E-cadherin, fibronectin) was determined via reverse transcription-polymerase chain reaction (RT-PCR) and
western blot analysis. The proliferative potential of AM was evaluated via a proliferation assay using 5-Bromo-2-
deoxyuridine (BrdU) incorporation and western blot analysis for proliferating cell nuclear antigen (PCNA). In addition,
enzyme-linked immunosorbent assay (ELISA) was used to measure the protein concentrations of mitogenic growth factors
(epidermal growth factor [EGF], keratinocyte growth factor [KGF], hepatocyte growth factor [HGF], and basic fibroblast
growth factor [bFGF]) in AM suspensions.
Results: Migration assay rates were enhanced as AM concentrations increased, with statistically significant changes seen
in 30% AM-treated and positive control cells, compared to negative control cells (p<0.05). RT-PCRs revealed that the
expression of the MMP9 gene was upregulated by AM, and the expressions of E-cadherin and fibronectin genes were
downregulated by AM. Western blot analysis demonstrated significantly higher MMP9 expression in AM-treated groups,
versus significantly lower levels of E-cadherin and fibronectin expression in AM-treated groups. Immunocytochemistry
showed large quantities of E-cadherin near the wound edges after 24 h of injury in the AM-treated groups. The proliferation
assay showed that the BrdU positive cell counts/total cell counts (labeling index) were augmented by AM to a statistically
significant degree (p<0.05 in the 30% AM and positive control groups). Western blot analysis showed that the expression
cell cycle-associated protein, PCNA, increased gradually as a result of AM treatment. ELISA showed that our AM
suspension contained 4 growth factors (HGF, EGF, KGF, and FGF). The amount of HGF was especially large, followed
by that of EGF.
Conclusions: These results demonstrate that the suspension form of AM maintains its beneficial effect on corneal epithelial
wound healing in vitro, and that AM suspension leads to significant increases in corneal epithelial migration and
proliferation with increasing AM concentrations.
After the use of the amniotic membrane (AM) as a graft
for ocular surface reconstruction was first described by Kim
and  Tseng  in  1995  [1],  the  popularity  of  this  surgical
procedure has increased. It has been well established that
transplantation of AM as a temporary or permanent graft
promotes epithelial wound healing and exerts profound anti-
inflammatory and anti-scarring effects on the ocular surface
[2,3]. Among these various functions of AM, AM-induced
reepithelialization  is  believed  to  occur  via  a  dual  action
mechanism,  involving  both  a  mechanical  effect  and  a
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biochemical effect. Mechanically, AM provides a basement
membrane-type substrate to the injured corneal epithelium
[4-6]. Additionally, the hydration of the epithelium and the
protection of the corneal epithelium from upper-lid irritation
may play a role. The biochemical mechanism by which AM
transplantation  might  influence  ocular  surface
reepithelialization involves the activity of growth factors. The
biochemical  factors  known  to  be  involved  in
reepithelialization  are  epidermal  growth  factor  (EGF),
keratinocyte growth factor (KGF), hepatocyte growth factor
(HGF), and basic fibroblast growth factor (bFGF)—derived
from  the  AM  epithelium  [7].  These  factors  have  been
identified as key materials in epithelialization, particularly in
cell migration and proliferation [8,9].
Extensive  studies  have  previously  been  conducted
involving  AM  grafts  or  patches  [1-3,10].  However,  the
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2230biochemical extracellular cues that induce reepithelialization
by  AM  are  currently  poorly  understood.  This  is  because,
clinically, AMs have generally been utilized as temporary or
permanent grafts. The importance of the mechanical functions
of AMs, rather than their biochemical functions, has been the
predominant  focus  of  previous  studies.  Additionally,  the
clinical applications of AM grafts or patches are generally
limited to severe cases of ocular surface disease, because they
require an invasive surgical procedure, which may cause a
variety of suture-related complications [10]. Therefore, the
development of a topically applicable AM suspension, the
biochemical effect of which on corneal wound healing could
be maintained for long periods, would be beneficial. The
principal objective of this study was to define the biochemical
role of AM suspensions on corneal epithelial wound healing,
particularly  with  regard  to  epithelial  proliferation  and
migration.
METHODS
Amniotic membrane suspension preparation: In accordance
with the tenets of the Declaration of Helsinki, after properly
acquiring informed consent, human AM was obtained at the
time of elective cesarean deliveries from the tissue bank of
Seoul St.Mary’s Hospital (Seoul, ROK) and processed as
described in a previous report [11]. In brief, AM was obtained
from the placenta, which tested serologically negative for
human immunodeficiency virus, hepatitis B and C viruses,
and syphilis. The placentas were maintained in sterile plastic
bags on ice during transfer, and were handled at all times using
sterile technique. Under a lamellar-flow hood, the placentas
were rinsed several times to remove excess blood clots, with
0.9% normal saline containing 50 mg/ml of penicillin, 50 mg/
ml of streptomycin, 100 mg/ml of neomycin, and 2.5 mg/ml
of  amphotericin  B.  The  AM  were  separated  from  the
remaining  chorion  via  blunt  dissection  using  two  sets  of
forceps while immersed in Earle’s Balanced Salt Solution
(Gibco  BRL  Life  Technologies,  Gaithersburg,  MD)
containing  the  aforementioned  antibiotics.  Following
separation from the chorion, the AM was sliced into smaller
pieces using tenotomy scissors. For the extraction of proteins
from AM, three methods were employed. First, a homogenizer
was  used  under  sterile  conditions.  After  grinding  the
membrane, further protein extraction was conducted using a
sonicator.  Finally,  the  liquefied  AM  suspension  was
lyophilized to prevent damage to the AM suspension from the
long preservation period, and to maintain the suspension’s
bioactivity. The powdered AM was dissolved with Dulbecco's
Modified Eagle Medium: F-12 medium (1:1; Welgene, ROK)
and centrifuged for 10 min at 10,000 rpm. The supernatant
was carefully separated and diluted to 10%, 15%, and 30%
with Dulbecco's Modified Eagle Medium: Nutrient Mixture
F-12 media. For the negative control, Dulbecco's Modified
Eagle Medium: Nutrient Mixture F-12 media was used. The
positive control’s culture reagents are listed below.
Culture of HCECs and culture reagents: SV40-immortalized
(transfected) human corneal epithelial cells (HCECs) were
kindly  provided  by  Dr.  Kaoru  Araki-Sasaki  (Osaka
University, Osaka, Japan). Cells were cultured in Dulbecco's
Modified  Eagle  Medium:  Nutrient  Mixture  F-12  medium
containing 5% fetal bovine serum, 5 mg/ml insulin (Sigma,
St. Louis, MO), 10 ng/ml human EGF (Sigma), 100 ng/ml
cholera toxin (Biomol, Plymouth, PA), and 0.5% dimethyl
sulfoxide (Sigma).
Effect of amniotic membrane suspension on cell migration in
vitro: Chambers in six-well plates were filled with 2.0 ml
culture reagents containing 1×105 cells and incubated for 36
h at 37 °C. Confluent cells in six-well plates were wounded
by manual scraping four times with a yellow pipette tip to
cross each other. Cells were washed once, and 2 ml of 0%,
5%, and 30% AM, and serum containing culture reagents,
were placed in each well. Cell migration was microscopically
assessed  after  24  h  of  scraping,  followed  by  4%
paraformaldehyde fixation and 0.2% crystal violet staining.
Each group was assayed in triplicate. The extent of healing
was determined by the ratio of the difference between the the
wound areas at the zero hour and the wound areas remaining
after 24 h.
Cell proliferation assay: Cell proliferation was assessed via a
5-Bromo-2’-deoxy-uridine (BrdU) incorporation assay. BrdU
staining was conducted using a 5-Bromo-2’-deoxy-uridine
Labeling and Detection Kit I (Roche Diagnostics, IN). 5-
Bromo-2-deoxyuridine (100 μg/ml) (BrdU; Sigma–Aldrich)
was added to the culture wells 20 min prior to fixation with
70% ethanol in 50 mM glycine (pH 2.0). After washing with
PBS three times, the wells were incubated with anti-BrdU
antibody (1:100) for 30 min at 37 °C. The bound antibody was
detected with anti anti-mouse Ig-fluorescein antibody (Alexa
Fluor® 488 goat anti-mouse IgG, 1/400; Invitrogen, Carlsbad,
CA) for 30 min at room temperature. Hoechst (1 mg/ml,
1/1,000) staining was conducted for 10 min at RT. Digital
images of each well were captured using a 100X objective.
The labeling index (the BrdU-positive portion of the HCECs)
was defined as BrdU-positive cells divided by the total count
(done in triplicate) of cells stained with Hoechest.
Reverse transcription-polymerase chain reaction (RT-PCR):
Total RNA was extracted from HCEC using TRIzol reagent
(Invitrogen) in accordance with the manufacturer’s protocol.
Total RNA (2 mg) was reverse-transcribed with AMV reverse
transcriptase  (Promega,  Madison,  WI),  and  the  PCR  was
conducted with specific primers. The primers utilized for RT-
PCR were as follows: Fibronectin-1 (forward: TCC GTG
GTT GTA TCA GGA CT, reverse: GAC ATC TGG CTT
GAT GGT TC, 270 bp); E-cadherin (forward: AAC CTC
TGT GAT GGA GGT CA, reverse: GGA TTG AAG ATC
GGA GGA TT, 297 bp); and hMMP9 (forward: CCT GGA
GAC CTG AGA ACC AA, reverse: GGA CCA CAA CTC
GTC  ATC  G,  549  bp).  Glyceraldehyde-3-phosphate
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endogenous reference to determine the integrity of the mRNA
in each sample. The PCR experiments were normalized to the
GAPDH expression. In order to assess the relative expression
of E-cadherin, Fibronectin-1, and MMP9, their band densities
were  measured  via  densitometric  analysis  (Image  Master
VDS 2.0; Pharmacia Biotech Inc., San Francisco, CA).
Western blot analysis: For western blot analysis, the HCECs
were harvested in a RIPA buffer (25 mM Tris–HCl, pH 7.4,
1% Tween-20, 0.1% SDS, 0.5% sodium deoxycholate, 10%
glycerol, 150 mM NaCl, 5 mM EDTA, 1 mM PMSF, 50 mM
NaF, 1 mM Na3VO4, 1 μg/ml of aprotinin, leupeptin, and
pepstatin). Protein concentrations were determined using a
bicinchoninic acid assay protein assay kit (Pierce, Rockford,
IL). The lysates were boiled for 5 min in a 1X sodium dodecyl
sulfate sample buffer, loaded and separated onto 10% sodium
dodecyl sulfate polyacrylamide gel electrophoresis gel, then
transferred to a nitrocellulose membrane (Amersham Life
Science,  Cleveland,  OH)  using  electrotransfer  apparatus
(Amersham). Approximately 5% skim milk in Tris Buffered
Saline plus 0.1% Tween-20 was used as an antibody blocking
and  dilution  buffer.  The  membrane  was  developed  using
enhanced  chemiluminescence  solution  (Santa  Cruz,  Santa
Cruz,  CA).  Pre-stained  molecular  weight  standards  were
purchased from Elpis-Biotech (Korea). b-Actin was utilized
as an endogenous reference to determine the integrity of the
protein in each sample. The Antibodies employed in this study
were obtained as follows: the proliferating cell nuclear antigen
(PCNA) was from Santa Cruz. The Fibronectin-1 was from
Santa  Cruz.  E-cadherin  was  purchased  from  Zymed
Laboratories. MMP9 was from Santa Cruz. Actin was from
Sigma.
Immunocytochemistry:  To  evaluate  cell  adhesion  at  the
wound margin, we utilized E-cadherin as an adhesion marker.
For immunocytochemical detection of E-cadherin, HCECs
were cultured in six-well chamber slides. Cells were wounded
via manual scraping with a yellow pipette tip. The wounded
cells were incubated for 24 h with 0% AM, 5% AM, and 30%
AM,  and  serum  containing  Dulbecco's  Modified  Eagle
Medium: Nutrient Mixture F-12. After the removal of the
medium, cells were washed three times with PBS, and 1.0 ml
of 4.0% paraformaldehyde was added to each well. The cells
were fixed for 20 min at room temperature (RT) and blocked
for 1 h with 2% bovine serum albumin (BSA). Mouse anti-E-
cadherin  antibody  (1:1,000;  Zymed)  was  applied  and
incubated for 1 h at RT. Slides were washed three times with
PBS and incubated for 1 h at RT with goat-anti-mouth-Alexa
546 (Invitrogen). The cells were rinsed with PBS, and nuclei
were counterstained with Hoechst 33342 (1:500) for 10 min
at RT. The samples were then observed with a fluorescence
microscope (Axiovert 200; Zeiss, Germany).
Figure 1. Migration assay by manual wounding of human corneal epithelial cells. HCECs were wounded by a yellow-tip in six-well plates.
A–D: Wounds in the negative control, amniotic membrane (AM) suspensions of 5% and 30%, and the positive control (SP) healed after 24
h. E: Statistically significantly increased healing rates, as compared to the negative controls were noted in the 30% AM, and positive controls
groups (asterisk).
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2232ELISA for detection of growth factors from AM suspensions:
AM suspensions were used for growth factor assay. First, total
protein was measured using the BCA protein assay kit by the
Bradford method in AM suspensions. The ratio of each growth
factor to total protein (pg/mg) was calculated. Then, growth
factor levels were measured using commercially available
ELISA systems (EGF, KGF, HGF, bFGF; R&D Systems,
Minneapolis, MN).
Statistical  Analysis:  Data  was  compared  to  the  negative
control (0% AM), and were expressed as mean±SD. Statistical
analysis was conducted via an independent t-test between the
negative  control  and  the  experimental  group  using  SPSS
(Version 14); the significance value was p<0.05.
RESULTS
Effect of amniotic membrane suspension on cell migration in
vitro: In the migration assay, migration rates were increased
in  accordance  with  the  AM  concentration.  The  cornea
epithelial migration rate in the negative control cells, the 5%
and 30% AM-treated cells, and the positive control cells were,
respectively,  2.20±0.39%,  12.37±13.60%,  73.24±16.00%,
and 83.73±4.00%. The statistically significant differences in
wound healing rates compared to the negative control were
noted in the 30% AM-treated cells and positive control cells.
(p<0.05; Figure 1).
Gene expressions by suspension of AM: Semiquantitative RT-
PCR using normalization to GAPDH showed that the mean
levels of gene expression for E-cadherin in the 5% AM, 30%
AM,  and  positive  control  groups  were,  respectively,
0.88±0.19, 0.52±0.11, and 1.15±0.48 fold greater than that for
the  negative  control  group  (Figure  2A).  Statistically
significant differences in gene expression, as compared to the
negative control, were noted in the 30% AM group (p<0.05).
Mean levels of gene expression for Fibronectin-1 in the 5%,
30%,  and  positive  control  groups  were,  respectively,
0.79±0.06, 0.66±0.05, and 0.55±0.31 fold greater than that for
the negative control group. Statistically significant increases
were noted in the 5% AM (p<0.05), 30% AM (p<0.001), and
positive control groups (p<0.001; Figure 2B). Mean levels of
gene expression for MMP9 in the 5% AM, 30% AM, and
positive  control  groups  were,  respectively,  1.33±0.14,
1.89±0.34,  and  1.92±0.24  fold  greater  than  that  for  the
negative control group. Statistically significant increases were
noted in the 5% AM, 30% AM, and positive control groups
(p<0.05; Figure 2C). Significantly more expression of MMP9
was noted in groups treated with increasing concentrations of
AM, whereas significantly less expression of E-cadherin and
fibronectin were observed in groups treated with AM.
The results of western blot analysis demonstrated that the
expression  for  E-cadherin  in  the  5%  AM,  30%  AM,  and
positive  control  groups  were,  respectively,  0.88±0.19-,
0.52±0.11-,  and  1.15±0.48  fold  greater  than  that  for  the
negative control group (Figure 3B). Statistically significant
increases compared to negative control were noted in the 30%
AM  and  positive  control  groups  (p<0.05).  Fibronectin-1
expression in the 5% AM, 30% AM, and positive control
groups  were,  respectively,  0.68±0.03,  0.62±0.06,  and
0.57±0.07 fold greater than that in the negative control group.
Figure  2.  The  effects  of  amniotic  membrane  suspensions  on  E-
cadherin, Fibronectin-1, and MMP9 in corneal epithelial cells human
corneal  epithelial  cells.  RT-PCR  and  densitometric  analyses
demonstrated that human corneal epithelial cells exposed to amniotic
membrane suspensions (0%, 5%, and 30%), and the positive controls
(SP) evidenced increased levels of MMP9 mRNA (p<0.05 in 5% and
30% AM, and SP). On the other hand, the expressions of E-cadherin
and  Fibronectin-1  were  reduced  in  accordance  with  the  AM
concentration. The values displayed in these graphs are expressed as
the  means±SD  of  triplicate  determinations  in  a  representative
experiment.  PCR  experiments  were  normalized  to  the  levels  of
GAPDH expression.
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30%  AM,  and  positive  control  groups  (p<0.001,  in  each
group; Figure 3C). Additionally, MMP9 expression in the 5%
AM, 30% AM, and positive control groups were, respectively,
Figure 3. Western blot analysis of proliferating cell nuclear antigen,
E-cadherin, Fibronectin-1, and MMP9 The results are representative
of three independent experiments. Western blot and densitometric
analyses demonstrated that HCECs exposed to AM (5% and 30%)
evidenced increased levels of PCNA and MMP9 protein (p<0.05 and
p<0.001, respectively), whereas HCECs exposed to AM (5% and
30%)  exhibited  reduced  expression  levels  of  E-cadherin  and
Fibronectin-1  (p<0.05  and  p<0.001,  respectively).  The  values
displayed in these graphs are expressed as the means±SD of triplicate
determinations  in  a  representative  experiment.  Values  were
normalized to that of the actin expression.
2.56±0.34, 2.80±0.60, and 2.83±0.74 fold greater than that in
the negative control group. Statistically significant changes
were noted in the 5% AM, 30% AM, and positive control
groups (p<0.001, in each group; Figure 3D). We noted a
tendency toward higher MMP9 in accordance with the AM
concentration,  whereas  lower  levels  of  E-cadherin  and
fibronectin expression were noted in accordance with the AM
concentration, a finding consistent with the RT-PCR results.
Effects  of  amniotic  membrane  suspension  on  cellular
proliferation activity: In order to determine whether the AM
concentration  correlated  with  the  proliferative  activity
occurring in HCECs monolayers in vitro, we conducted BrdU-
labeling experiments with the negative control and at different
AM concentrations. The results showed that there were a
number of BrdU-labeled nuclei (green) in cultured HCEC
monolayers  (Figure  4).  The  average  labeling  index  was
4.7±3.8% in the negative control and 7.8±2.0% in the 5% AM-
treated cells, 12.6±0.1% in the 30% AM-treated cells, and
15.4±1.9% in the positive control-treated cells. Statistically
significant changes, compared to the negative control, were
noted in the 30% AM and positive control groups (Figure 2;
p=0.014 and 0.017, respectively). These results verified that
the topical application of AM correlated with the proliferative
potential in HCEC monolayers. Western blot analysis showed
that  the  expression  cell  cycle-associated  protein,  PCNA,
increased gradually in accordance with the concentration of
AM  (Figure  3A).  The  results  of  densitometric  analyses
demonstrated that HCECs exposed to AM exhibited increased
PCNA expression, in direct relation to the concentration of
AM. Significant differences (p<0.05) were noted in the 5%
and 30% AM groups.
Immunocytochemistry  for  E-cadherin:
Immunocytochemistry  showed  that  large  quantities  of  E-
cadherin were deposited near the edges of the wounds after
24 h of injury (Figure 5). E-cadherin was detected near the
cell boundaries and between cells. The levels of E-cadherin
expression  gradually  increased  according  to  the  AM
concentration.
Concentrations  of  mitogenic  growth  factors  in  AM
suspensions:  Each  growth  factor  contained  in  the  AM
suspension is shown in Table 1. HGF was most prevalent,
followed  by  EGF.  Relatively  small  amounts  of  KGF  and
bFGF were contained in the AM suspension.
DISCUSSION
Renewal of the corneal epithelium is a complex process that
involves the migration, proliferation, and differentiation of
epithelial cells. These events perform an important role in
maintaining barrier function and corneal transparency [12].
Reepithelialization, which is the regrowth of epithelia over a
denuded surface, begins immediately after tissue injury [12].
It requires that epithelial cells at the edge of the wounded
tissue  loosen  their  cell–cell  and  cell–ECM  contacts  and
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wound edge begin to migrate, the epithelial cells behind the
wound edge begin to proliferate, and this continues until a new
epithelium  covers  the  damaged  tissue  [14,15].  Multiple
MMPs  have  been  associated  with  the  migratory  phase  of
wound  repair,  and  these  include  MMP1,  MMP3,  MMP7,
MMP9,  MMP10,  MMP14,  and  MMP28  [16-19].  Among
these MMPs, MMP9, or gelatinase B, has also been implicated
in reepithelialization after injury [12]. The epidermal growth
factor  (EGF)  and  hepatocyte  growth  factor  (HGF)  both
stimulate keratinocyte migration in wound assays in vitro
[16]. This cell migration is dependent on the induction of
MMP9 activity, and is impaired by the presence of either the
blockage of MMP9 antibodies or a general MMP inhibitor
[16].
As described previously, the biochemical factors known
to be involved in reepithelialization are HGF, EGF, FGF, and
KGF—derived  from  the  AM  epithelium  [7].  Firstly,  we
attempted to investigate whether our AM suspension also
included  these  mitogenic  growth  factors.  Our  study
demonstrated that the AM suspension contained these growth
factors, especially a large amount of HGF, followed by EGF
(Table  1).  The  mechanism  of  reepithelialization  via  AM
suspension appears to be predominantly mediated by HGF
and  EGF.  Second,  we  attempted  to  define  the  migratory
mechanism of AM via the MMP9 pathway. MMP9 expression
is shown to increase with increasing AM concentration in both
RT-PCR and western blot analysis (Figure 2 and Figure 3).
The invasion of cells into surrounding tissue is a multistep
process,  which  additionally  requires  changes  in  cell:cell
contacts  and  cell:substrate  interactions,  as  well  as  the
degradation of the extracellular matrix by metalloproteinases.
The possible substrates of MMP9 include gelatin, elastin,
fibronectin,  collagen  I/IV/V/VII/X/XI,  laminin,  aggrecan,
vitronectin, etc. [19]. Among these substrates, we evaluated
fibronectin and E-cadherin as substrates for MMP9. In our
study, Fibronectin-1 and E-cadherin expression were shown
to decrease in accordance with AM concentration (Figure 2
and Figure 3).
Another aspect of reepithelialization is the proliferation
of epithelial cells behind the migrating wound front. In this
study,  western  blot  analysis  for  PCNA  demonstrated
increased expression according to AM concentration, where
the expression of PCNA in 30% AM cells was greater than
that  in  the  positive  control  cells  (Figure  3).  The  BrdU
incorporation assay also indicated that proliferative potential
increased in accordance with AM concentration in HCECs.
Therefore, the migratory potential of the positive control
containing serum seems to be superior to that of the 30% AM
suspension, whereas the proliferative potential of the positive
control  appears  to  be  lower  than  that  of  the  30%  AM
suspension. Thus, we hypothesize that 30% AM exerts more
effect on proliferation than on migration in corneal epithelial
wound  healing.  As  previously  described,  the  process  of
migration requires the cells at the wound margin to loosen
their  cell–cell  and  cell–ECM  contacts,  as  well  as  the
Figure 4. Gradual increase in proliferative potential according to the amniotic membrane concentration in human corneal epithelial cells
monolayers. 5-Bromo-2-deoxyuridine (BrdU) labeling (green) in the nucleus (blue, stained with 4',6-diamidino-2-phenylindole [DAPI]) was
conducted to evaluate the proliferative potential of human corneal epithelial cells monolayers cultured at 0% amniotic membrane (A), 5%
AM (B), 30% AM (C), and that of the positive control (D). E: Statistically significant increases in proliferative potential, as compared to the
negative controls, were noted in the 30% AM and positive control groups (asterisk; N=3; Scale bar, 200 µm).
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2235degradation of the ECM molecule [13]. It is possible that the
excellent proliferative ability of AM may partially disturb
epithelial cell migration via the continuous production of the
ECM  molecule  and  the  inhibition  of  ECM  degradation.
Immunocytochemical detection of E-cadherin showed that E-
cadherin expression increases in accordance with the AM
concentration, particularly on the wound margin (Figure 5).
However, the total expression of E-cadherin, as determined
by RT-PCR and western blot analysis (Figure 2 and Figure 3),
evidences a decreasing pattern, in accordance with the AM
concentration. This discrepancy may be related to the fact that
wound  healing  is  a  complex  process  that  requires  the
appropriate  temporal  and  spatial  expression  of  signaling
molecules and their receptors; the expression levels of cellular
adhesion molecules and ECM proteins may therefore differ.
In  this  study,  AM  suspensions  were  prepared  via
lyophilization (freeze-drying) and centrifugation in order to
preserve the mitogenic growth factor proteins. Koizumi et al.
[7] reported that higher levels of certain growth factors (e.g.,
EGF, KGF, HGF, and bFGF) were noted in the amniotic
Figure 5. Immunocytochemical detection of E-cadherin on human corneal epithelial cells. E-cadherin expression (red) in wounded cells at
different concentration of amniotic membrane suspensions (0% [A], 5% [B], 30% [C], and positive control groups [D]) are shown at 100X
magnification. Cell nuclei were stained with 4',6-diamidino-2-phenylindole (blue). The levels of E-cadherin expression were increased
gradually according to the amniotic membrane concentration (Scale bar, 200 μm).
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2236epithelium, as compared to the amniotic stroma. Thus, we did
not remove the epithelium from the AM. The results of our
study show that the suspension form of AM served to maintain
the  previously  established  effects  of  AM  graft
reepithelialization.
Serum drops, as well as AM transplantation techniques,
represent important recent advances in the treatment of ocular
surface diseases [3]. Although autologous serum also has a
valuable effect on corneal wound healing, the AM has some
advantages  over  autologous  serum,  as  the  AM  has  anti-
inflammatory and anti-scarring properties as well. The use of
autologous  serum  is  limited,  largely  owing  to  fears  of
proinflammatory properties or microbial excretion [20-24].
AM  has  previously  been  shown  to  evidence  antibacterial
properties  against  Pseudomonas,  hemolytic  group  A
Streptococcus,Staphylococcus aureus, and Escherichia coli
[22,25]. Gicquel et al. [26] previously reported that early
amniotic membrane transplantation can be used as a safe
adjuvant therapy during antibacterial treatment in cases of
severe bacterial keratitis. Thus, AM suspension appears to be
the drug of choice in obstinate cases of epithelial defects
accompanying inflammation, particularly in cases in which
infection is suspected. Additionally, it has been suggested that
AM suspension may be utilized in scarless, fast epithelial
healing in LASEK (laser epithelial keratomileusis) with the
proven anti-scarring, anti-inflammatory effects of AM.
In summary, our observations indicate that the AM in
suspension form facilitated the maintenance of the beneficial
biochemical  effect  on  corneal  epithelial  migration  and
proliferation  in  vitro,  and  the  AM  suspension  exerted  a
positive  effect  on  corneal  epithelial  migration  and
proliferation, in accordance with its concentration. Further
detailed  studies  will  be  necessary  to  elucidate  the  exact
mechanism as to how AM suspensions induce the migration
and proliferation of epithelial cells.
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